InMed Pharmaceuticals Inc. (INM) P/E Ratio, ROE & Key Statistics
$15.56NASDAQ: INMMarket Cap $8.55M
Data as of Nov 9, 2026 close · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for InMed Pharmaceuticals Inc. (INM), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-0.38
P/B ratioShare price divided by book value per share.
5.42
P/S ratioMarket value divided by annual revenue.
0.63
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
30.44%
Operating marginRevenue left after operating costs.
-2.47%
Net marginRevenue left after every cost, including tax and interest.
-0.61%
Return on equityProfit as a percentage of shareholders’ equity.
-134.73%
Return on assetsProfit as a percentage of total assets.
-414.54%
Return on capital employedOperating profit against the capital the business uses.
-995.44%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
6.00
Debt to equityTotal borrowings against shareholders’ equity.
0.00
Interest coverageHow many times operating profit covers the interest bill.
-496.36
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
−$3.12
Market capitalisationShare price times shares outstanding.
$8.55M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$7.23M
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
InMed Pharmaceuticals Inc. (INM) statistics — frequently asked questions
What is InMed Pharmaceuticals Inc.'s P/E ratio?
InMed Pharmaceuticals Inc. (INM) trades on a price-to-earnings ratio of -0.38. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is InMed Pharmaceuticals Inc.'s return on equity?
InMed Pharmaceuticals Inc. (INM) reports a return on equity of -134.73%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does InMed Pharmaceuticals Inc. carry?
InMed Pharmaceuticals Inc. (INM) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.
What is InMed Pharmaceuticals Inc.'s profit margin?
InMed Pharmaceuticals Inc. (INM) keeps -0.61% of revenue as net profit after every cost, including tax and interest.